{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:06:18Z","timestamp":1784739978205,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00428-018-2364-7","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T22:09:51Z","timestamp":1525730991000},"page":"513-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["PD-L1 receptor expression in vulvar carcinomas is HPV-independent"],"prefix":"10.1007","volume":"473","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8565-0798","authenticated-orcid":false,"given":"M.","family":"Choschzick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"2364_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.gene.2017.09.050","volume":"638","author":"KN Berger","year":"2018","unstructured":"Berger KN, Pu JJ (2018) PD-1 pathway and its clinical application: a 20year journey after discovery of the complete human PD-1 gene. Gene 638:20\u201325","journal-title":"Gene"},{"key":"2364_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coph.2015.05.011","volume":"23","author":"J Sunshine","year":"2015","unstructured":"Sunshine J, Taube JM (2015) PD-1\/PD-L1 inhibitors. Curr Opin Pharmacol 23:32\u201338","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"2364_CR3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/AOG.0b013e31819bd6e0","volume":"113","author":"JS Smith","year":"2009","unstructured":"Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM (2009) Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 113(4):917\u2013924","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2364_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/jamaoncol.2015.6326","volume":"2","author":"BE Howitt","year":"2016","unstructured":"Howitt BE et al (2016) Genetic basis for PD-L1 expression in squamous cell carcinomas of the cervix and vulva. JAMA Oncol 2(4):518\u2013522","journal-title":"JAMA Oncol"},{"issue":"10066","key":"2364_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","volume":"389","author":"A Rittmeyer","year":"2017","unstructured":"Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, Frontera OA, de Marinis F, Turna H, Lee JS, Ballinger M, Kowanetz M, He P, Chen DS, Sandler A, Gandara DR (2017) Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet 389(10066):255\u2013265","journal-title":"Lancet"},{"issue":"10030","key":"2364_CR6","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0140-6736(16)00587-0","volume":"387","author":"L Fehrenbacher","year":"2016","unstructured":"Fehrenbacher L, Spira A, Ballinger M, Kowanetz M, Vansteenkiste J, Mazieres J, Park K, Smith D, Artal-Cortes A, Lewanski C, Braiteh F, Waterkamp D, He P, Zou W, Chen DS, Yi J, Sandler A, Rittmeyer A (2016) Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet 387(10030):1837\u20131846","journal-title":"Lancet"},{"issue":"12","key":"2364_CR7","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1097\/PAS.0000000000000516","volume":"39","author":"DA Kerr","year":"2015","unstructured":"Kerr DA, Arora KS, Mahadevan KK, Hornick JL, Krane JF, Rivera MN, Ting DT, Deshpande V, Faquin WC (2015) Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma. Am J Surg Pathol 39(12):1643\u20131652","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2364_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13000-018-0689-9","volume":"13","author":"M Udall","year":"2018","unstructured":"Udall M, Rizzo M, Kenny J, Doherty J, Dahm SA, Robbins P, Faulkner E (2018) PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics. Diagn Pathol 13(1):12","journal-title":"Diagn Pathol"},{"issue":"54","key":"2364_CR9","doi-asserted-by":"publisher","first-page":"92890","DOI":"10.18632\/oncotarget.21641","volume":"8","author":"T Hecking","year":"2017","unstructured":"Hecking T et al (2017) Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology. Oncotarget 8(54):92890\u201392903","journal-title":"Oncotarget"},{"issue":"2","key":"2364_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ygyno.2016.05.019","volume":"142","author":"LJ Lee","year":"2016","unstructured":"Lee LJ, Howitt B, Catalano P, Tanaka C, Murphy R, Cimbak N, DeMaria R, Bu P, Crum C, Horowitz N, Matulonis U, Viswanathan AN (2016) Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy. Gynecol Oncol 142(2):293\u2013298","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2364_CR11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","volume":"19","author":"A Garcia-Diaz","year":"2017","unstructured":"Garcia-Diaz A et al (2017) Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep 19(6):1189\u20131201","journal-title":"Cell Rep"},{"issue":"6","key":"2364_CR12","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","volume":"73","author":"S Lyford-Pike","year":"2013","unstructured":"Lyford-Pike S et al (2013) Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res 73(6):1733\u20131741","journal-title":"Cancer Res"},{"issue":"13","key":"2364_CR13","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","volume":"19","author":"BJ Chen","year":"2013","unstructured":"Chen BJ et al (2013) PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res 19(13):3462\u20133473","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2364_CR14","doi-asserted-by":"publisher","first-page":"12024","DOI":"10.18632\/oncotarget.7593","volume":"7","author":"M Straub","year":"2016","unstructured":"Straub M, Drecoll E, Pfarr N, Weichert W, Langer R, Hapfelmeier A, G\u00f6tz C, Wolff KD, Kolk A, Specht K (2016) CD274\/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity. Oncotarget 7(11):12024\u201312034","journal-title":"Oncotarget"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-018-2364-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2364-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2364-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T19:43:37Z","timestamp":1557258217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-018-2364-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["2364"],"URL":"https:\/\/doi.org\/10.1007\/s00428-018-2364-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"14 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}